Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.6.3, indicating the study record has been updated to the latest revision. This change reflects a metadata revision on the page rather than an update to the substantive study information.SummaryDifference0.1%

- Check13 days agoChange DetectedThe revision label changed from v3.6.0 to v3.6.2, indicating a minor page/system update.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status was updated to No longer looking for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The label for Intervention/Treatment was standardized and the revision/version label updated to v3.6.0.SummaryDifference0.4%

- Check34 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating a small backend/content management system update to this page. This update does not change the visible content or the information presented about the study.SummaryDifference0.1%

- Check42 days agoChange DetectedThe results status changed from 'No Results Posted' to 'Results Submitted', indicating that outcome data are being submitted for posting and will be available after processing.SummaryDifference0.1%

- Check49 days agoChange DetectedA PubMed citation related to the study was added to the Publications section. A line noting that some publications are automatically filled from PubMed was included.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.